147 related articles for article (PubMed ID: 34669021)
1. RNA-binding protein CELF1 promotes cardiac hypertrophy via interaction with PEBP1 in cardiomyocytes.
Hu X; Wu P; Liu B; Lang Y; Li T
Cell Tissue Res; 2022 Jan; 387(1):111-121. PubMed ID: 34669021
[TBL] [Abstract][Full Text] [Related]
2. Promoting role of circ-Jarid2/miR-129-5p/Celf1 axis in cardiac hypertrophy.
Fang Y; Tao Y; Zhou H; Lai H
Gene Ther; 2021 Dec; 28(12):718-728. PubMed ID: 32632266
[TBL] [Abstract][Full Text] [Related]
3. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.
Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J
J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330
[TBL] [Abstract][Full Text] [Related]
4. Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway.
Chen Y; Ge Z; Huang S; Zhou L; Zhai C; Chen Y; Hu Q; Cao W; Weng Y; Li Y
Aging (Albany NY); 2020 Mar; 12(6):5362-5383. PubMed ID: 32209725
[TBL] [Abstract][Full Text] [Related]
5. A positive feedback regulation of Heme oxygenase 1 by CELF1 in cardiac myoblast cells.
Liu Y; Wang H; Wang J; Wei B; Zhang X; Zhang M; Cao D; Dai J; Wang Z; Nyirimigabo E; Ji G
Biochim Biophys Acta Gene Regul Mech; 2019 Feb; 1862(2):209-218. PubMed ID: 30508596
[TBL] [Abstract][Full Text] [Related]
6. Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.
Markandeya YS; Phelan LJ; Woon MT; Keefe AM; Reynolds CR; August BK; Hacker TA; Roth DM; Patel HH; Balijepalli RC
J Biol Chem; 2015 Sep; 290(36):22085-100. PubMed ID: 26170457
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1-dependent pathway.
Miao R; Lu Y; He X; Liu X; Chen Z; Wang J
J Cell Mol Med; 2020 Sep; 24(18):10946-10957. PubMed ID: 32798288
[TBL] [Abstract][Full Text] [Related]
9. Identification of Targets of CUG-BP, Elav-Like Family Member 1 (CELF1) Regulation in Embryonic Heart Muscle.
Blech-Hermoni Y; Dasgupta T; Coram RJ; Ladd AN
PLoS One; 2016; 11(2):e0149061. PubMed ID: 26866591
[TBL] [Abstract][Full Text] [Related]
10. SWAP70 Overexpression Protects Against Pathological Cardiac Hypertrophy in a TAK1-Dependent Manner.
Qian Q; Hu F; Yu W; Leng D; Li Y; Shi H; Deng D; Ding K; Liang C; Liu J
J Am Heart Assoc; 2023 Apr; 12(7):e028628. PubMed ID: 36974751
[TBL] [Abstract][Full Text] [Related]
11. C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.
Zhang B; Zhang P; Tan Y; Feng P; Zhang Z; Liang H; Duan W; Jin Z; Wang X; Liu J; Gao E; Yu S; Yi D; Sun Y; Yi W
Cell Death Dis; 2019 Jul; 10(7):520. PubMed ID: 31285424
[TBL] [Abstract][Full Text] [Related]
12. Dual-Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1.
Zhao J; Jiang X; Liu J; Ye P; Jiang L; Chen M; Xia J
J Am Heart Assoc; 2021 Feb; 10(4):e014311. PubMed ID: 33522247
[TBL] [Abstract][Full Text] [Related]
13. Mnk1 (Mitogen-Activated Protein Kinase-Interacting Kinase 1) Deficiency Aggravates Cardiac Remodeling in Mice.
Yuan Y; Yan L; Wu QQ; Zhou H; Jin YG; Bian ZY; Deng W; Yang Z; Shen DF; Zeng XF; Wang SS; Li H; Tang QZ
Hypertension; 2016 Dec; 68(6):1393-1399. PubMed ID: 27698061
[TBL] [Abstract][Full Text] [Related]
14. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy.
Gao L; Huang K; Jiang DS; Liu X; Huang D; Li H; Zhang XD; Huang K
Hypertension; 2015 Apr; 65(4):871-81. PubMed ID: 25646292
[TBL] [Abstract][Full Text] [Related]
15. TBC1D25 Regulates Cardiac Remodeling Through TAK1 Signaling Pathway.
Guo S; Liu Y; Gao L; Xiao F; Shen J; Xing S; Yang F; Zhang W; Shi Q; Li Y; Zhao L
Int J Biol Sci; 2020; 16(8):1335-1348. PubMed ID: 32210723
[TBL] [Abstract][Full Text] [Related]
16. Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β-Activated Kinase 1-Dependent Signaling Pathways.
Chen L; Huang J; Ji YX; Mei F; Wang PX; Deng KQ; Jiang X; Ma G; Li H
Hypertension; 2017 Feb; 69(2):249-258. PubMed ID: 27956576
[TBL] [Abstract][Full Text] [Related]
17. FBXW5 acts as a negative regulator of pathological cardiac hypertrophy by decreasing the TAK1 signaling to pro-hypertrophic members of the MAPK signaling pathway.
Hui X; Hu F; Liu J; Li C; Yang Y; Shu S; Liu P; Wang F; Li S
J Mol Cell Cardiol; 2021 Feb; 151():31-43. PubMed ID: 32971071
[TBL] [Abstract][Full Text] [Related]
18. STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress.
Zhang Y; Chen W; Wang Y
Biomed Pharmacother; 2020 May; 125():110022. PubMed ID: 32106379
[TBL] [Abstract][Full Text] [Related]
19. Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.
Liu Y; Jiang XL; Liu Y; Jiang DS; Zhang Y; Zhang R; Chen Y; Yang Q; Zhang XD; Fan GC; Li H
Cardiovasc Res; 2014 Jan; 101(1):87-96. PubMed ID: 24285748
[TBL] [Abstract][Full Text] [Related]
20. De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
Lu P; Xu Y; Sheng ZY; Peng XG; Zhang JJ; Wu QH; Wu YQ; Cheng XS; Zhu K
Exp Cell Res; 2021 Sep; 406(1):112761. PubMed ID: 34339675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
